Memphasys Ltd has released a press release.
Equine fertility study positions Felix as leading technology
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- Felix sales clinical trial and Oxidative Stress devel update
- Animal activity update - oxidative stress measurement system
- Dr David Ali appointed full-time Chief Executive Officer
- Investor Presentation
- Felix Japanese trial provides sperm preparation benefits
Later from Memphasys
- Response to ASX Query
- Voluntary Suspension
- A$2 million capital raising
- Reinstatement to Official Quotation
- Positive initial study results - Felix equine application
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys